Global Health Risk Framework: A Workshop on Research and Development of Medical Products
The U.S. Institute of Medicine (IOM) of the National Academies of Sciences, Engineering, and Medicine will serve as the secretariat for an independent global commission that will conduct a study to recommend an effective global architecture for recognizing and mitigating the threat of epidemic infectious diseases. The commission will receive input from four IOM workshops on governance for global health, financing response to pandemic threats, resilient health systems, and research and development of medical products, which will be coordinated.
This workshop will inform the Commission prior to the final release of its report by providing a forum for relevant stakeholders to describe and provide input on the core needs and strategies to facilitate development of medical products to prevent, diagnose, treat, and protect from emerging global infectious diseases. The focus of the workshop will be on global systems and policy needs to foster communication, partnerships, and other strategies to advance medical product development.
The workshop will focus on strategies to facilitate the development of medical products– including therapeutics, vaccines, diagnostics, and personal protective equipment. Key areas for consideration include: product development, clinical development, optimization for development, regulatory review standards and systems, manufacturing, legal issues, and indicators relevant to medical product research and development.
The workshop is co-hosted by Hong Kong University and will be held on August 19-21, 2015. Participants will be invited from around the world to engage in dialogue and identify potential avenues for collaboration.
Previous Meetings for this Activity
August 19, 2015 - August 21, 2015 (12:00 AM Eastern)